Working together to accelerate patient access to advanced therapies

Find out how we’re
driving innovation,
in support of routine
delivery of ATMPs

Three centres: One network

At sites across the UK, the NHS and industry are working to provide ready to use systems and solutions to accelerate adoption of advanced therapies

iMATCH
Midlands – Wales
Northern Alliance

Coordinated by Cell and Gene Therapy Catapult

iMATCH is a Manchester based consortium focused on the scale-up of activity in ATMPs. We aim to improve patient access to ATMPs whilst ensuring safe and efficient delivery.
Key objectives

To maximise access of ATMP to patients through integration of sample collection
To develop electronic sample traceability and tracking systems through novel digital solutions
To develop innovative systems of clinical data capture for ATMPs
To ensure safe delivery of ATMPs through education, communication and dissemination

Visit this centre

The Midlands and Wales Advanced Therapy Treatment Centre (MW-ATTC) consists of a large regional network with the necessary commercial and NHS infrastructure required to facilitate the delivery of advanced therapy treatments to patients.

Key objectives

Programme Management
Clinical Delivery
Logistics
Manufacture
Economic Evaluation
Informatics

Visit this centre

The Northern Alliance Advanced Therapies Treatment Centre (NAATTC), formally established in March 2018, is a consortium of twenty industry, NHS and academic organisations led by Newcastle Hospitals and SNBTS.